{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:41:35Z","timestamp":1784734895755,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aims to assess the predictive value of the Systemic Immune Inflammation Index (SII) in determining in-stent restenosis (ISR) likelihood in patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention (PCI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study enrolled 903 ACS patients undergoing PCI, categorized into ISR (+) and ISR (\u2212) groups based on control coronary angiography results. Demographic, clinical, laboratory, and angiographic-procedural characteristics were systematically compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The ISR (+) group encompassed 264 individuals (29.2%), while the ISR (\u2212) group comprised 639 individuals (70.8%). Patients had a mean age of 55.8\u2005\u00b1\u200510.2 years, with 69% being male. The ISR (+) group had higher diabetes and smoking prevalence and notably larger stent dimensions. Lab parameters showed significantly elevated creatinine, total cholesterol, red cell distribution width, white blood cell and neutrophil counts, SII index and C-reactive protein (CRP) in the ISR (+) group, while lymphocyte levels were lower. Binary logistic regression identified stent diameter (odds ratio [OR]: 0.598, 95% confidence interval [CI]: 0.383\u20130.935; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.024), stent length (OR: 1.166, 95% CI: 1.132\u20131.200; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001), creatinine (OR: 0.366, 95% CI: 0.166\u20130.771; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.003), CRP (OR: 1.075, 95% CI: 1.042\u20131.110; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.031), and SII index (OR: 1.014, 95% CI: 1.001\u20131.023; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001) as independent ISR predictors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The SII index exhibits potential as a predictive marker for ISR in ACS patients post-PCI, indicating systemic inflammation and heightened restenosis risk. Integrating the SII index into risk models could identify high-risk patients for targeted interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001325","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T10:00:45Z","timestamp":1704448845000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Systemic immune inflammation index and its implication on in-stent restenosis among patients with acute coronary syndrome"],"prefix":"10.1097","volume":"35","author":[{"given":"Altu\u011f","family":"\u00d6sken","sequence":"first","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat","family":"Polat","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"\u00c7akir","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Zengin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Nazmi","family":"\u00c7alik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eennur","family":"\u00dcnal Dayi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne\u015fe","family":"\u00c7am","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Sciences University Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/heartjnl-2017-312755","article-title":"Percutaneous coronary intervention for stable coronary artery disease.","volume":"105","author":"Al-Lamee","year":"2019","journal-title":"Heart"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(01)01742-9","article-title":"Coronary in-stent restenosis: current status and future strategies.","volume":"39","author":"Lowe","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"e007023","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023","article-title":"Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review.","volume":"12","author":"Shlofmitz","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0003319719830495","article-title":"Blood cell parameters and predicting coronary in-stent restenosis.","volume":"70","author":"Wang","year":"2019","journal-title":"Angiology"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.amjcard.2012.07.003","article-title":"Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.","volume":"110","author":"Turak","year":"2012","journal-title":"Am J Cardiol"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.amjcard.2005.01.055","article-title":"Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.","volume":"95","author":"Dibra","year":"2005","journal-title":"Am J Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/hrt.2008.153114","article-title":"Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents.","volume":"95","author":"Kang","year":"2009","journal-title":"Heart"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2143\/AC.59.4.2005204","article-title":"The relationship between preprocedural platelet size and subsequent in-stent restenosis.","volume":"59","author":"Norgaz","year":"2004","journal-title":"Acta Cardiol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MCA.0000000000000105","article-title":"Preprocedural red blood cell distribution width predicts bare metal stent restenosis.","volume":"25","author":"Yildiz","year":"2014","journal-title":"Coron Artery Dis"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.","volume":"32","author":"Abizaid","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"key":"R12-20250729","first-page":"457","article-title":"Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?","volume":"43","author":"Tanindi","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ehj.2004.04.027","article-title":"Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.","volume":"25","author":"Segev","year":"2004","journal-title":"Eur Heart J"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-511X-13-41","article-title":"Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement.","volume":"13","author":"Zheng","year":"2014","journal-title":"Lipids Health Dis"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0003319717752245","article-title":"Evaluation of preprocedural laboratory parameters as predictors of drug-eluting stent restenosis in coronary chronic total occlusion lesions.","volume":"70","author":"Li","year":"2019","journal-title":"Angiology"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"e23108","DOI":"10.1002\/jcla.23108","article-title":"Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents.","volume":"34","author":"Sun","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"R17-20250729","first-page":"49","article-title":"Impact of C-reactive protein on in-stent restenosis: a meta-analysis.","volume":"37","author":"Li","year":"2010","journal-title":"Tex Heart Inst J"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.carrev.2008.01.003","article-title":"Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.","volume":"9","author":"Ferrante","year":"2008","journal-title":"Cardiovasc Revasc Med"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinbiochem.2017.11.008","article-title":"Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis.","volume":"52","author":"Dong","year":"2018","journal-title":"Clin Biochem"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCA.0000000000000221","article-title":"Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.","volume":"26","author":"Zhao","year":"2015","journal-title":"Coron Artery Dis"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MCA.0b013e328362ba8a","article-title":"Association of baseline high-density lipoprotein levels with restenosis after coronary stenting: a meta-analysis.","volume":"24","author":"He","year":"2013","journal-title":"Coron Artery Dis"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ahj.2005.01.032","article-title":"Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.","volume":"150","author":"Halkin","year":"2005","journal-title":"Am Heart J"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"75381","DOI":"10.18632\/oncotarget.18856","article-title":"Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis.","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"933913","DOI":"10.3389\/fcvm.2022.933913","article-title":"Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis.","volume":"9","author":"Ye","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","article-title":"Coronary in-stent restenosis: JACC state-of-the-art review.","volume":"80","author":"Giustino","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MCA.0000000000001117","article-title":"Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction.","volume":"33","author":"\u00d6cal","year":"2022","journal-title":"Coron Artery Dis"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/00033197211030053","article-title":"Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction.","volume":"73","author":"Ba\u011fci","year":"2022","journal-title":"Angiology"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/00033197211029094","article-title":"Systemic immune-inflammation index is a predictor of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction.","volume":"73","author":"\u00d6zt\u00fcrk","year":"2022","journal-title":"Angiology"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/00033197211007738","article-title":"Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with non-ST segment elevation myocardial infarction.","volume":"72","author":"Kelesoglu","year":"2021","journal-title":"Angiology"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/bmm-2020-0838","article-title":"Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction.","volume":"15","author":"Ba\u011fci","year":"2021","journal-title":"Biomark Med"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/pace.14436","article-title":"Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction.","volume":"45","author":"Hayiro\u011flu","year":"2022","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:03:08Z","timestamp":1753812188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001325","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}